作者
Evangelos Vassos, Marta Di Forti, Jonathan Coleman, Conrad Iyegbe, Diana Prata, Jack Euesden, Paul O’Reilly, Charles Curtis, Anna Kolliakou, Hamel Patel, Stephen Newhouse, Matthew Traylor, Olesya Ajnakina, Valeria Mondelli, Tiago Reis Marques, Poonam Gardner-Sood, Katherine J Aitchison, John Powell, Zerrin Atakan, Kathryn E Greenwood, Shubulade Smith, Khalida Ismail, Carmine Pariante, Fiona Gaughran, Paola Dazzan, Hugh S Markus, Anthony S David, Cathryn M Lewis, Robin M Murray, Gerome Breen
发表日期
2017/3/15
期刊
Biological psychiatry
卷号
81
期号
6
页码范围
470-477
出版商
Elsevier
简介
Background
Polygenic risk scores (PRSs) have successfully summarized genome-wide effects of genetic variants in schizophrenia with significant predictive power. In a clinical sample of first-episode psychosis (FEP) patients, we estimated the ability of PRSs to discriminate case-control status and to predict the development of schizophrenia as opposed to other psychoses.
Methods
The sample (445 case and 265 control subjects) was genotyped on the Illumina HumanCore Exome BeadChip with an additional 828 control subjects of African ancestry genotyped on the Illumina Multi-Ethnic Genotyping Array. To calculate PRSs, we used the results from the latest Psychiatric Genomics Consortium schizophrenia meta-analysis. We examined the association of PRSs with case-control status and with schizophrenia versus other psychoses in European and African ancestry FEP patients and in a second sample of 248 case …
引用总数
2016201720182019202020212022202320244163436383832254
学术搜索中的文章